Martin Schlaeger

1.9k total citations
18 papers, 266 citations indexed

About

Martin Schlaeger is a scholar working on Immunology, Dermatology and Oncology. According to data from OpenAlex, Martin Schlaeger has authored 18 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Dermatology and 7 papers in Oncology. Recurrent topics in Martin Schlaeger's work include Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Martin Schlaeger is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Martin Schlaeger collaborates with scholars based in Germany, Switzerland and Austria. Martin Schlaeger's co-authors include Matthias Augustin, Alexander Nast, Sandra Philipp, Ralph von Kiedrowski, Tobias Weberschock, Joachim Klaus, H.M. Ockenfels, Thomas Rosenbach, Kristian Reich and Ulrich Mrowietz and has published in prestigious journals such as Dermatology, JDDG Journal der Deutschen Dermatologischen Gesellschaft and Der Anaesthesist.

In The Last Decade

Martin Schlaeger

18 papers receiving 254 citations

Peers

Countries citing papers authored by Martin Schlaeger

Since Specialization

Citations

This map shows the geographic impact of Martin Schlaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schlaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schlaeger more than expected).

Fields of papers citing papers by Martin Schlaeger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Schlaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schlaeger. The network helps show where Martin Schlaeger may publish in the future.

Co-authorship network of co-authors of Martin Schlaeger

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Schlaeger. A scholar is included among the top collaborators of Martin Schlaeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Schlaeger. Martin Schlaeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität 2021 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph von Kiedrowski, Tobias Weberschock, Corinna Dressler	15
2	Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und Therapieempfehlungen 2021 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph von Kiedrowski, Tobias Weberschock, Corinna Dressler	21
3	German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations 2021 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph von Kiedrowski, Tobias Weberschock, Corinna Dressler	40
4	German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations 2021 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph von Kiedrowski, Tobias Weberschock, Corinna Dressler	28
5	S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 2 2019 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Lisa Eisert, Matthias Augustin, (unknown), Martin Dittmann, (unknown), Regina Fölster‐Holst, Sascha Gerdes, Henning Hamm, P. Höger, Gerd Horneff, Ralph von Kiedrowski, Sandra Philipp, (unknown), Martin Schlaeger, Volker Schuster, Petra Staubach, Tobias Weberschock, Ricardo Niklas Werner, Alexander Nast, Michael Sticherling	6
6	S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1 2019 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Lisa Eisert, Matthias Augustin, (unknown), Martin Dittmann, (unknown), Regina Fölster‐Holst, Sascha Gerdes, Henning Hamm, P. Höger, Gerd Horneff, Ralph von Kiedrowski, Sandra Philipp, (unknown), Martin Schlaeger, Volker Schuster, Petra Staubach, Tobias Weberschock, Ricardo Niklas Werner, Alexander Nast, Michael Sticherling	5
7	S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2 2019 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Lisa Eisert, Matthias Augustin, (unknown), Martin Dittmann, (unknown), Regina Fölster‐Holst, Sascha Gerdes, Henning Hamm, P. Höger, Gerd Horneff, Ralph von Kiedrowski, Sandra Philipp, (unknown), Martin Schlaeger, Volker Schuster, Petra Staubach, Tobias Weberschock, Ricardo Niklas Werner, Alexander Nast, Michael Sticherling	27
8	S1 Guidelines – Dermatoses associated with dermal lymphostasis 2018 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Joachim Dissemond, Finja Jockenhöfer, (unknown), (unknown), (unknown), S. Reich-Schupke, Martin Schlaeger, Erich Schubert, Markus Stücker, Tobias Weberschock, (unknown)	4
9	Aktinische Keratosen 2012 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Eggert Stockfleth, Dorothea Terhorst‐Molawi, Axel Hauschild, Christos C. Zouboulis, Martin Schlaeger, Claus Oster‐Schmidt, Thomas L. Diepgen, Claus Garbe, Harald Gollnick, (unknown), Hans F. Merk, Wolfram Sterry, Helmut Kerl, Carola Berking	15
10	Melanocytic nevi 2011 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Axel Hauschild, Friederike Egberts, Claus Garbe, Jürgen Bauer, Stephan Grabbe, Henning Hamm, Helmut Kerl, Michael Reusch, Rainer Rompel, Martin Schlaeger, (unknown)	9
11	Melanozytäre Nävi 2011 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Axel Hauschild, Friederike Egberts, Claus Garbe, Jürgen Bauer, Stephan Grabbe, Henning Hamm, Helmut Kerl, Michael Reusch, Rainer Rompel, Martin Schlaeger, (unknown)	3
12	S3‐Leitlinie zur Therapie der Psoriasis vulgaris – Update: „Übersicht der Therapieoptionen” und „Efalizumab” 2009 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Matthias Augustin, Wolf‐Henning Boehncke, Joachim Klaus, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Peter Weisenseel, Berthold Rzany	5
13	Evidence‐based (S3) guideline for the treatment of psoriasis vulgaris – Update: “Therapeutic options” and “Efalizumab” 2009 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Matthias Augustin, Wolf‐Henning Boehncke, Joachim Klaus, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Peter Weisenseel, Berthold Rzany	11
14	Neurodermitis S2‐Leitlinie 2008 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), Thomas Werfel, Werner Aberer, Matthias Augustin, Tilo Biedermann, Regina Fölster‐Holst, Frank Friedrichs, (unknown), Annice Heratizadeh, Alexander Kapp, Bernhard Przybilla, Ernst Rietschel, Martin Schlaeger, Peter Schmid‐Grendelmeier, (unknown), Doris Staab, Rüdiger Szczepanski, Dieter Vieluf, (unknown), Margitta Worm	32
15	Präklinisches Atemwegsmanagement in Norddeutschland 2007 ·Der Anaesthesist ·A. Timmermann, U. Braun, (unknown), Martin Schlaeger, (unknown), Bernhard Gräf	34
16	Melanozytäre Nävi 2006 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Axel Hauschild, Claus Garbe, Jürgen Bauer, Henning Hamm, Helmut Kerl, Michael Reusch, Rainer Rompel, Martin Schlaeger, (unknown)	6
17	Immunglobulin E bei kutanen Lymphomen und bei der Parapsoriasis en plaques (Brocq) 1980 ·Dermatology ·Martin Schlaeger	4
18	[Diagnostic value of RAST-classes in various allergens]. 1977 ·PubMed ·Martin Schlaeger, H Pullmann, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact